# CLINDAMYCIN PHOSPHATE AND TRETINOIN
> **ANDA212845** · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2022-02-10
## Drug
- **FDA Application Number:** ANDA212845
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLINDAMYCIN PHOSPHATE AND TRETINOIN
- **Generic name:** CLINDAMYCIN PHOSPHATE AND TRETINOIN
- **Active ingredients:** CLINDAMYCIN PHOSPHATE; TRETINOIN
- **Dosage form:** GEL
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SOLARIS PHARMA CORP
- **Manufacturer:** Solaris Pharma Corporation
- **First approval:** 2022-02-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212845)
---
*AI Analytics · CC0 1.0*